Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda

Table 6 Expected diagnostic yield and costs of MODS versus Xpert strategy across variable prevalence situations for a cohort of 10,000 HIV presumptive PTB patients

Prevalence/Strategy	Total TB cases detected	Cost per case detected	Total cost for cases detected	Ratio total cost
TB prevalence (10 %)
MODS	1060	62	65720
Xpert	970	128	124160	1.89
TB prevalence (20 %)
MODS	1920	34	65280
Xpert	1740	71	123540	1.89
TB prevalence (30 %)
MODS	2780	23	63940
Xpert	2510	49	122990	1.92

ISSN: 1472-6963